S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.54%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NASDAQ:ISRG

Intuitive Surgical (ISRG) Stock Forecast, Price & News

$291.43
+0.69 (+0.24%)
(As of 04:00 PM ET)
Compare
Today's Range
$288.55
$297.45
50-Day Range
$284.35
$349.70
52-Week Range
$180.07
$358.07
Volume
1.75 million shs
Average Volume
1.70 million shs
Market Capitalization
$102.41 billion
P/E Ratio
73.04
Dividend Yield
N/A
Price Target
$343.10

Intuitive Surgical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
18.3% Upside
$343.10 Price Target
Short Interest
Healthy
0.87% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.15
Upright™ Environmental Score
News Sentiment
1.03mentions of Intuitive Surgical in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$19.65 M Sold Last Quarter
Proj. Earnings Growth
15.23%
From $4.53 to $5.22 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.93 out of 5 stars

Medical Sector

58th out of 963 stocks

Surgical Appliances & Supplies Industry

5th out of 17 stocks


ISRG stock logo

About Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. is a leading medical technology company specializing in robotic-assisted surgical systems. Founded in 1995, the company's mission is to improve patient outcomes through the use of innovative technology and minimally invasive surgical techniques. Headquartered in Sunnyvale, California, Intuitive Surgical operates globally, serving healthcare professionals and patients in over 60 countries.

Intuitive Surgical's flagship product is the da Vinci Surgical System, a robotic platform that enables surgeons to perform complex procedures with enhanced precision, control, and visualization. The system consists of robotic arms controlled by the surgeon, along with a high-definition 3D camera and specialized surgical instruments. This advanced technology allows for smaller incisions, reduced scarring, shorter recovery times, and improved clinical outcomes.

The company's target market primarily includes hospitals and surgical centers specializing in urology, gynecology, general, and thoracic surgery. Intuitive Surgical has established itself as a leader in these fields and has a strong customer base, including prestigious medical institutions and renowned surgeons. The company's dedication to innovation and patient care has garnered numerous accolades, including recognition as one of Fortune's "World's Most Admired Companies" in the healthcare industry.

Intuitive Surgical is led by an experienced management team committed to driving the company's growth and maintaining its position as a leader in surgical robotics. Dr. Gary Guthart is the Chief Executive Officer and has been instrumental in guiding the company's strategic direction. Under his leadership, Intuitive Surgical has expanded its product portfolio, entered new markets, and achieved remarkable financial success.

Intuitive Surgical has consistently delivered strong financial performance over the past few years. The company's revenue has experienced steady growth, reaching $6.22 billion in the latest fiscal year. With a strong focus on operational efficiency, Intuitive Surgical has maintained healthy profit margins, enabling it to invest in research and development and expand its market reach.

The company has a solid balance sheet with manageable debt levels. This provides stability and financial flexibility for future investments and acquisitions. Intuitive Surgical's financial performance is notably impressive compared to industry benchmarks, reflecting its strong market position and competitive advantage.

Intuitive Surgical commands a premium compared to its industry peers. The company's price-to-earnings ratio, a commonly used valuation measure, is higher than average due to its strong growth prospects and dominant market position. Investors have recognized the company's innovation and potential for long-term success, contributing to its higher valuation.

Intuitive Surgical has exhibited remarkable stock performance in recent years. The company's share price has experienced significant growth, reflecting investor confidence in its business model and growth potential. Notably, the stock has outperformed broader market indices and many of its industry peers.

Intuitive Surgical operates in the rapidly evolving field of surgical robotics, which is transforming the healthcare landscape. The industry is characterized by intense competition, with major players including Medtronic, Johnson & Johnson, and Stryker Corporation. These companies continually invest in research and development to enhance their robotic surgical systems and expand their market presence.

Regulatory and political factors also play a significant role in the industry. Government agencies, such as the U.S. Food and Drug Administration (FDA), regulate the approval and safety of robotic surgical systems. Changes in regulations or introducing new policies can impact the industry landscape and market access for companies like Intuitive Surgical.

Despite the competitive landscape, Intuitive Surgical maintains a solid competitive advantage. The company's pioneering da Vinci Surgical System has established a dominant position in the market, with a large installed base worldwide. This gives Intuitive Surgical a significant edge in terms of customer loyalty and brand recognition. Additionally, the company's focus on continuous innovation and product development enables it to stay ahead of the competition.

Acquisitions and strategic partnerships offer growth opportunities for Intuitive Surgical. The company has a strong balance sheet enabling it to pursue strategic acquisitions that complement its existing product portfolio or provide access to new markets. Collaborating with other medical technology companies or research institutions can also fuel innovation and open doors to novel surgical solutions.

Like any company operating in the healthcare industry, Intuitive Surgical faces various risks and challenges. One significant risk is the potential for changes in healthcare policies and reimbursement rates. Government policies can directly impact the adoption and utilization of robotic surgical systems, which could affect the demand for Intuitive Surgical's products.

Another challenge is emerging new technologies or surgical techniques that may compete with or disrupt the robotic-assisted surgery market. Technological advancements in artificial intelligence and virtual reality could offer alternative solutions to traditional surgical procedures. Intuitive Surgical must stay at the forefront of innovation and adapt its offerings to remain competitive.

Additionally, the company faces the risk of product recalls or safety concerns. As robotic surgical systems become more complex, ensuring their reliability and patient safety becomes paramount. Intuitive Surgical must continue to invest in quality control measures, regulatory compliance, and ongoing training for surgeons to mitigate these risks.

ISRG Price History

ISRG Stock News Headlines

16 Top Robotics Companies to Get to Know in 2023 (ISRG)
What are the top robotics companies in the USA, as robotics continues to grow? Learn more about the best companies today with MarketBeat.
AI 2.0 is Here: How to Invest in a Generational Opportunity (ISRG)
AI is sweeping the world but don't confuse apples with oranges; here's a look at the top 5 advancements in AI and who is using it.
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Miso Robotics Stock: Is an IPO Coming Soon? (ISRG)
Can you buy Miso Robotics stock? Miso Robotics is not yet publicly traded, but there are other ways to get in on this branch of AI. Learn more.
The Top 5 Robot Stocks Automating Investment Returns Now (ISRG)
AI is hot and nowhere hotter than the applications that use it, including physical and software robots that automate business processes.
7 Best Robotics Stocks to Buy Now (ISRG)
What are the best robotics stocks to buy now, as AI continues to influence many sectors? Learn more about the best robotics stocks to buy now with MarketBeat.
Anthropic Stock: Is an IPO Coming Soon? (ISRG)
Can you buy Anthropic stock? Anthropic is not yet publicly traded, but there are other ways you can get in on this branch of AI. Learn more.
How to Buy OpenAI Stock: A Guide (ISRG)
Can you buy OpenAI stock? Open AI is not yet publicly traded, but there are other ways you can get in on this branch of artificial intelligence. Learn more.
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
7 Best AI Mutual Funds (and ETFs) to Sweep the AI Craze  (ISRG)
What are the best AI mutual funds, as AI continues to influence many sectors? Learn more about the best AI mutual funds to buy now with MarketBeat.
A Significant Reversal is in Sight for These 5 Med Tech Companies (ISRG)
Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand.
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M (ISRG)
3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up
Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade
10 Best Robotics ETFs
Have $1,500 to Invest? 2 Growth Stocks to Buy Now
See More Headlines
Receive ISRG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intuitive Surgical and its competitors with MarketBeat's FREE daily newsletter.

ISRG Company Calendar

Last Earnings
7/20/2023
Today
9/27/2023
Next Earnings (Confirmed)
10/19/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ISRG
CUSIP
46120E60
Employees
12,120
Year Founded
1995

Price Target and Rating

Average Stock Price Forecast
$343.10
High Stock Price Forecast
$400.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+18.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
20 Analysts

Profitability

Net Income
$1.32 billion
Pretax Margin
25.79%

Debt

Sales & Book Value

Annual Sales
$6.22 billion
Cash Flow
$4.81 per share
Book Value
$31.45 per share

Miscellaneous

Free Float
348,237,000
Market Cap
$102.12 billion
Optionable
Optionable
Beta
1.30

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Gary S. Guthart Ph.D. (Age 57)
    CEO & Director
    Comp: $2.23M
  • Mr. David J. RosaMr. David J. Rosa (Age 55)
    Pres
    Comp: $1.32M
  • Mr. Jamie E. SamathMr. Jamie E. Samath (Age 52)
    Sr. VP & CFO
    Comp: $886.86k
  • Mr. Marshall L. MohrMr. Marshall L. Mohr (Age 67)
    Exec. VP of Global Bus. Services
    Comp: $1.2M
  • Mr. Robert DeSantisMr. Robert DeSantis (Age 57)
    Exec. VP and Chief Strategy & Corp. Operations Officer
    Comp: $1.12M
  • Mr. Fredrik WidmanMr. Fredrik Widman
    VP, Principal Accounting Officer & Corp. Controller
  • Mr. Gary H. Loeb J.D. (Age 53)
    Sr. VP, Gen. Counsel & Chief Compliance Officer
  • Mr. Henry L. Charlton (Age 53)
    Sr. VP & Chief Commercial and Marketing Officer
  • Mr. Julian Nikolchev (Age 69)
    Sr. VP of Corp. Devel. & Ventures
  • Dr. Myriam J. Curet McAdams F.A.C.S. (Age 66)
    M.D., Exec. VP & Chief Medical Officer













ISRG Stock - Frequently Asked Questions

Should I buy or sell Intuitive Surgical stock right now?

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last twelve months. There are currently 5 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ISRG shares.
View ISRG analyst ratings
or view top-rated stocks.

What is Intuitive Surgical's stock price forecast for 2023?

20 Wall Street analysts have issued 1 year target prices for Intuitive Surgical's stock. Their ISRG share price forecasts range from $210.00 to $400.00. On average, they expect the company's stock price to reach $343.10 in the next year. This suggests a possible upside of 18.1% from the stock's current price.
View analysts price targets for ISRG
or view top-rated stocks among Wall Street analysts.

How have ISRG shares performed in 2023?

Intuitive Surgical's stock was trading at $265.35 on January 1st, 2023. Since then, ISRG stock has increased by 9.5% and is now trading at $290.61.
View the best growth stocks for 2023 here
.

When is Intuitive Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 19th 2023.
View our ISRG earnings forecast
.

How can I listen to Intuitive Surgical's earnings call?

Intuitive Surgical will be holding an earnings conference call on Thursday, October 19th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical, Inc. (NASDAQ:ISRG) released its earnings results on Thursday, July, 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.09. The medical equipment provider earned $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. Intuitive Surgical had a trailing twelve-month return on equity of 12.41% and a net margin of 21.38%. The company's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.85 EPS.
Read the conference call transcript
.

When did Intuitive Surgical's stock split?

Intuitive Surgical's stock split on the morning of Tuesday, October 5th 2021. The 3-1 split was announced on Thursday, August 5th 2021. The newly issued shares were payable to shareholders after the market closes on Monday, October 4th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What is Gary S. Guthart's approval rating as Intuitive Surgical's CEO?

431 employees have rated Intuitive Surgical Chief Executive Officer Gary S. Guthart on Glassdoor.com. Gary S. Guthart has an approval rating of 99% among the company's employees. This puts Gary S. Guthart in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Intuitive Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intuitive Surgical investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Salesforce (CRM), PayPal (PYPL), Walt Disney (DIS), Boeing (BA), Mastercard (MA) and Adobe (ADBE).

What is Intuitive Surgical's stock symbol?

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

Who are Intuitive Surgical's major shareholders?

Intuitive Surgical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Bank Julius Baer & Co. Ltd Zurich (183.70%), State Street Corp (4.22%), Capital World Investors (2.14%), Bank of New York Mellon Corp (2.03%), Alliancebernstein L.P. (1.98%) and Geode Capital Management LLC (1.88%). Insiders that own company stock include Alan J Levy, Amal M Johnson, Amy L Ladd, Craig H Barratt, Craig H Barratt, Curet Myriam, David J Rosa, David J Rosa, Fredrik Widman, Gary S Guthart, Gary S Guthart, Jamie Samath, Keith R Leonard, Mark J Rubash, Mark J Rubash, Marshall Mohr, Myriam Curet, Reiter Kara Andersen and Robert Desantis.
View institutional ownership trends
.

How do I buy shares of Intuitive Surgical?

Shares of ISRG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Intuitive Surgical's stock price today?

One share of ISRG stock can currently be purchased for approximately $290.61.

How much money does Intuitive Surgical make?

Intuitive Surgical (NASDAQ:ISRG) has a market capitalization of $102.12 billion and generates $6.22 billion in revenue each year. The medical equipment provider earns $1.32 billion in net income (profit) each year or $3.99 on an earnings per share basis.

How many employees does Intuitive Surgical have?

The company employs 12,120 workers across the globe.

Does Intuitive Surgical have any subsidiaries?
The following companies are subsidiares of Intuitive Surgical: Computer Motion, Intuitive Surgical AB, Intuitive Surgical ApS, Intuitive Surgical Australia Proprietary Limited, Intuitive Surgical BV, Intuitive Surgical Brasil Importacao E Comercio De Equipamentos Cirurgicos Ltda, Intuitive Surgical Canada Inc, Intuitive Surgical Deutschland GmbH, Intuitive Surgical Fosun HongKong Co Ltd, Intuitive Surgical Fosun Medical Technology Shanghai Co Ltd, Intuitive Surgical GK, Intuitive Surgical HK Limited, Intuitive Surgical Holdings LLC, Intuitive Surgical India Private Limited, Intuitive Surgical International BV, Intuitive Surgical International Finance LLC, Intuitive Surgical Ireland Limited, Intuitive Surgical Israel Ltd, Intuitive Surgical Korea Limited, Intuitive Surgical Limited, Intuitive Surgical Medical Device Science & Technology Shanghai Co Ltd, Intuitive Surgical Medical Device Taiwan Ltd, Intuitive Surgical Operations Inc, Intuitive Surgical Optics Gmbh, Intuitive Surgical Pte Ltd, Intuitive Surgical S de R L de CV, Intuitive Surgical SAS, Intuitive Surgical SPRL, Intuitive Surgical Sarl, Intuitive Surgical Sarl Taiwan Branch, Intuitive Surgical Service Optics Inc, Intuitive Surgical Spain SL, Intuitive Surgical Turkey Medikal Cihaz Ticaret Limited Serketi, Intuitive Surgical sro, Intuitive Ventures Fund I LLC, NeoGuide Systems, Orpheus Medical, Orpheus Medical Gmbh, Orpheus Medical Inc, Orpheus Medical Ltd, Orpheus Medical USA Inc, and Scholly Micro Optics Gmbh.
Read More
How can I contact Intuitive Surgical?

Intuitive Surgical's mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The official website for the company is www.intuitive.com. The medical equipment provider can be reached via phone at (408) 523-2100, via email at investor.relations@intusurg.com, or via fax at 408-523-1390.

This page (NASDAQ:ISRG) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -